Adherence to EULAR's recommendations on comorbidity management minimizes the discontinuation of bDMARDS for intolerance in patients with chronic inflammatory rheumatic diseases

Joint Bone Spine. 2021 Dec;88(6):105234. doi: 10.1016/j.jbspin.2021.105234. Epub 2021 Jun 5.

¹ Department of Rheumatology, Grenoble-Alpes University, Grenoble Hospital, Grenoble, France. Electronic address: lisareyes@hotmail.fr.
² Department of Public Health, Grenoble-Alpes University, Grenoble Hospital, Grenoble, France.
³ Department of Rheumatology, Grenoble-Alpes University, Grenoble Hospital, Grenoble, France; GREPI, TIMC UMR 5525, Grenoble-Alpes University, Grenoble, France.
⁴ Department of Rheumatology, Aix-Marseille University, Sainte-Marguerite Hospital, Marseille, France.
⁵ Department of Pharmacology, Grenoble-Alpes University, Grenoble Hospital, Grenoble, France.
⁶ Department of Rheumatology, Grenoble-Alpes University, Grenoble Hospital, Grenoble, France.

No abstract available

Keywords: Comorbidities; Retention rate; Rheumatoid arthritis; Spondyloarthritis.

Publication types